D.E. Shaw & Co
LUMO

D.E. Shaw & Co’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

D.E. Shaw & Co’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,687
Closed -$306K – 3933
2018
Q1 		$306K Buy
+4,687
New +$332K ﹤0.01% 3142
2017
Q4 		– Sell
-2,492
Closed -$228K – 3782
2017
Q3 		$228K Sell
2,492
-2,175
-47% -$167K ﹤0.01% 3254
2017
Q2 		$309K Sell
4,667
-16,042
-77% -$1.99M ﹤0.01% 3020
2017
Q1 		$4.49M Buy
20,709
+8,120
+65% +$1.16M 0.01% 1362
2016
Q4 		$1.16M Buy
12,589
+9,363
+290% +$1.06M ﹤0.01% 2372
2016
Q3 		$436K Buy
3,226
+306
+10% +$30.4K ﹤0.01% 2865
2016
Q2 		$296K Sell
2,920
-591
-17% -$73.3K ﹤0.01% 3023
2016
Q1 		$575K Sell
3,511
-2
-0.1% -$405 ﹤0.01% 2708
2015
Q4 		$1.15M Sell
3,513
-1,467
-29% -$478K ﹤0.01% 2548
2015
Q3 		$1.61M Sell
4,980
-516
-9% -$227K ﹤0.01% 2254
2015
Q2 		$2.19M Buy
+5,496
New +$2.34M ﹤0.01% 2132
2015
Q1 		– Sell
-876
Closed -$313K – 4091
2014
Q4 		$313K Sell
876
-3,387
-79% -$1.01M ﹤0.01% 3627
2014
Q3 		$822K Sell
4,263
-1,217
-22% -$268K ﹤0.01% 2974
2014
Q2 		$1.31M Buy
5,480
+4,336
+379% +$882K ﹤0.01% 2690
2014
Q1 		$293K Sell
1,144
-5,443
-83% -$1.66M ﹤0.01% 3921
2013
Q4 		$1.3M Buy
+6,587
New +$1.17M ﹤0.01% 2929

Other funds holding LUMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co's LUMO Position: Q2 2018 in Review

D.E. Shaw & Co sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 4,687 shares — an estimated $306K sold.

D.E. Shaw & Co first reported a position in LUMO in Q4 2013 and held it in 16 quarters. The position peaked at $4.49M in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

  • D.E. Shaw & Co reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,687 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $306K.
  • D.E. Shaw & Co first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 16 quarters.
  • D.E. Shaw & Co's Lumos Pharma, Inc. Common Stock position peaked at $4.49M in Q1 2017.
  • 106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on D.E. Shaw & Co's 13F filing for Q2 2018, filed 14 Aug 2018.